-
Company Insights
Innovation and Patenting activity of Royal BAM Group NV Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Royal BAM Group NV Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aldafermin in Constipation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aldafermin in Constipation report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aldafermin in Constipation Drug Details: Aldafermin (NGM-282) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aldafermin in Liver Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aldafermin in Liver Cirrhosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aldafermin in Liver Cirrhosis Drug Details: Aldafermin (NGM-282) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aldafermin in Liver Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aldafermin in Liver Fibrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aldafermin in Liver Fibrosis Drug Details: Aldafermin (NGM-282) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aldafermin in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aldafermin in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aldafermin in Type 2 Diabetes Drug Details: Aldafermin (NGM-282) is under...
-
Sector Analysis
Bosnia Insurance Industry – Key Trends and Opportunities to 2028
Bosnia Insurance Market Report Overview The gross written premium of the Bosnia insurance market was BAM963.1 million ($502.9 million) in 2023. The market is expected to achieve a CAGR of more than 5% during 2024-2028. The Bosnia insurance market research report provides in-depth market analysis, information, and insights into the Bosnia insurance industry. It provides a detailed outlook by product category as well as values for key performance indicators such as gross written premium, penetration, premium accepted and ceded, profitability...
-
Product Insights
Sita – Roosendaal Waste To Energy Plant
Sita - Roosendaal Waste To Energy Plant is a biopower project located in North Brabant, Netherlands. The project was developed by BAM Civiel bv; Hitachi Zosen Inova AG. The project came online in 2011. Empower your strategies with our Sita - Roosendaal Waste To Energy Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
Moerdijk Waste To Energy Plant
Moerdijk Waste To Energy Plant is a biopower project located in North Brabant, Netherlands. The project is owned by Attero Holding NV; Indaver N.V. and was developed by BAM Civiel bv; Hitachi Zosen Inova AG; Kraftanlagen Energies & Services GmbH. The project came online in 1997. Empower your strategies with our Moerdijk Waste To Energy Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered...
-
Product Insights
Glaucoma Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Glaucoma Surgery Devices Pipeline Market Report Overview Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways to provide effective intra-ocular pressure. Glaucoma drainage devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule forms about 4-6 weeks after surgery and regulates flow. The Glaucoma Surgery Devices pipeline market research report provides comprehensive information about the Glaucoma surgery devices pipeline products with a comparative analysis of the products at...